1. Home
  2. BHRB vs DRUG Comparison

BHRB vs DRUG Comparison

Compare BHRB & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burke & Herbert Financial Services Corp.

BHRB

Burke & Herbert Financial Services Corp.

HOLD

Current Price

$63.62

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$84.73

Market Cap

856.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHRB
DRUG
Founded
1852
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
856.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BHRB
DRUG
Price
$63.62
$84.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$71.67
$106.75
AVG Volume (30 Days)
72.6K
265.5K
Earning Date
01-22-2026
02-13-2026
Dividend Yield
3.43%
N/A
EPS Growth
173.76
N/A
EPS
7.72
N/A
Revenue
$340,508,000.00
N/A
Revenue This Year
$24.79
N/A
Revenue Next Year
$8.99
N/A
P/E Ratio
$8.30
N/A
Revenue Growth
46.12
N/A
52 Week Low
$47.57
$23.18
52 Week High
$70.51
$123.75

Technical Indicators

Market Signals
Indicator
BHRB
DRUG
Relative Strength Index (RSI) 46.32 49.60
Support Level $63.50 $83.50
Resistance Level $67.76 $87.58
Average True Range (ATR) 1.73 4.38
MACD 0.02 -1.00
Stochastic Oscillator 22.27 18.63

Price Performance

Historical Comparison
BHRB
DRUG

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: